Dostęp publiczny

Functional heterogeneity of human memory CD4+ T cell clones primed by pathogens or vaccines

S Becattini, D Latorre, F Mele, M Foglierini, C De Gregorio, A Cassotta, ...

Science 347 (6220), 400-406, 2015

Upoważnienia: Swiss National Science Foundation, European Commission

Rapid development of broadly influenza neutralizing antibodies through redundant mutations

L Pappas, M Foglierini, L Piccoli, NL Kallewaard, F Turrini, C Silacci, ...

Nature 516 (7531), 418-422, 2014

Upoważnienia: Swiss National Science Foundation, US National Institutes of Health …

Cross-neutralization of four paramyxoviruses by a human monoclonal antibody

D Corti, S Bianchi, F Vanzetta, A Minola, L Perez, G Agatic, B Guarino, ...

Nature 501 (7467), 439-443, 2013

Upoważnienia: Swiss National Science Foundation

Design of customized coronavirus receptors

P Liu, ML Huang, H Guo, M McCallum, JY Si, YM Chen, CL Wang, X Yu, ...

Nature 635 (8040), 978-986, 2024

Upoważnienia: Howard Hughes Medical Institute

Dostępne w jakimś miejscu: 145

Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody

D Pinto, YJ Park, M Beltramello, AC Walls, MA Tortorici, S Bianchi, ...

Nature 583 (7815), 290-295, 2020

Upoważnienia: US Department of Energy, US National Institutes of Health

SARS-CoV-2 B. 1.617. 2 Delta variant replication and immune evasion

P Mlcochova, SA Kemp, MS Dhar, G Papa, B Meng, IATM Ferreira, R Datir, ...

Nature 599 (7883), 114-119, 2021

Upoważnienia: Bill & Melinda Gates Foundation, Department of Biotechnology, India, UK …

Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology

L Piccoli, YJ Park, MA Tortorici, N Czudnochowski, AC Walls, ...

Cell 183 (4), 1024-1042. e21, 2020

Upoważnienia: US Department of Energy, US National Institutes of Health

[PDF] cuso.ch

A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins

D Corti, J Voss, SJ Gamblin, G Codoni, A Macagno, D Jarrossay, ...

Science 333 (6044), 850-856, 2011

Upoważnienia: Swiss National Science Foundation, US National Institutes of Health

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

E Cameroni, JE Bowen, LE Rosen, C Saliba, SK Zepeda, K Culap, ...

Nature 602 (7898), 664-670, 2022

Upoważnienia: Bill & Melinda Gates Foundation, US National Institutes of Health, Howard …

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity

B Meng, A Abdullahi, IATM Ferreira, N Goonawardane, A Saito, I Kimura, ...

Nature 603 (7902), 706-714, 2022

Upoważnienia: Bill & Melinda Gates Foundation, US National Institutes of Health, Howard …

Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies

RE Chen, X Zhang, JB Case, ES Winkler, Y Liu, LA VanBlargan, J Liu, ...

Nature medicine 27 (4), 717-726, 2021

Upoważnienia: US Department of Defense, US National Institutes of Health

N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2

M McCallum, A De Marco, FA Lempp, MA Tortorici, D Pinto, AC Walls, ...

Cell 184 (9), 2332-2347. e16, 2021

Upoważnienia: US Department of Energy, US National Institutes of Health, Natural Sciences …

[PDF] science.org

Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection

K Stettler, M Beltramello, DA Espinosa, V Graham, A Cassotta, S Bianchi, ...

Science 353 (6301), 823-826, 2016

Upoważnienia: Swiss National Science Foundation, US National Institutes of Health …

An infectious SARS-CoV-2 B. 1.1. 529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies

LA VanBlargan, JM Errico, PJ Halfmann, SJ Zost, JE Crowe Jr, LA Purcell, ...

Nature medicine 28 (3), 490-495, 2022

Upoważnienia: US Department of Defense, US National Institutes of Health

Sensitivity of SARS-CoV-2 B. 1.1. 7 to mRNA vaccine-elicited antibodies

DA Collier, A De Marco, IATM Ferreira, B Meng, RP Datir, AC Walls, ...

Nature 593 (7857), 136-141, 2021

Upoważnienia: Bill & Melinda Gates Foundation, US National Institutes of Health, UK …

Unexpected receptor functional mimicry elucidates activation of coronavirus fusion

AC Walls, X Xiong, YJ Park, MA Tortorici, J Snijder, J Quispe, E Cameroni, ...

Cell 176 (5), 1026-1039. e15, 2019

Upoważnienia: US National Institutes of Health, Netherlands Organisation for Scientific …

Spread of a SARS-CoV-2 variant through Europe in the summer of 2020

EB Hodcroft, M Zuber, S Nadeau, TG Vaughan, KHD Crawford, ...

Nature 595 (7869), 707-712, 2021

Upoważnienia: Swiss National Science Foundation, US National Institutes of Health, Howard …

Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity

EC Thomson, LE Rosen, JG Shepherd, R Spreafico, A da Silva Filipe, ...

Cell 184 (5), 1171-1187. e20, 2021

Upoważnienia: US Department of Energy, Bill & Melinda Gates Foundation, US National …

[HTML] science.org

Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms

MA Tortorici, M Beltramello, FA Lempp, D Pinto, HV Dang, LE Rosen, ...

Science 370 (6519), 950-957, 2020

Upoważnienia: Bill & Melinda Gates Foundation, US National Institutes of Health, Research …

[PDF] science.org